ABCG1 – A potential therapeutic target for atherosclerosis
Authors:
- 1 January 2007
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 69 (1) , 214-217
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Emerging Therapies Targeting High-Density Lipoprotein Metabolism and Reverse Cholesterol TransportCirculation, 2006
- New Insights Into the Regulation of HDL Metabolism and Reverse Cholesterol TransportCirculation Research, 2005
- High-density lipoproteins as therapeutic targetsCurrent Opinion in Lipidology, 2005
- HDL as a target in the treatment of atherosclerotic cardiovascular diseaseNature Reviews Drug Discovery, 2005
- Expression and Regulation of Multiple Murine ATP-binding Cassette Transporter G1 mRNAs/Isoforms That Stimulate Cellular Cholesterol Efflux to High Density LipoproteinJournal of Biological Chemistry, 2004
- ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteinsProceedings of the National Academy of Sciences, 2004
- Regulation and Mechanisms of ATP-Binding Cassette Transporter A1-Mediated Cellular Cholesterol EffluxArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Specific Binding of ApoA-I, Enhanced Cholesterol Efflux, and Altered Plasma Membrane Morphology in Cells Expressing ABC1Journal of Biological Chemistry, 2000
- ABCG1 (ABC8), the human homolog of theDrosophila whitegene, is a regulator of macrophage cholesterol and phospholipid transportProceedings of the National Academy of Sciences, 2000
- The ABCs of cholesterol effluxNature Genetics, 1999